CYP11B2 and atrial fibrillation: The implication of our findings that CYP11B2 genotype is associated with both AF risk and elevated aldosterone is that CYP11B2 may be a useful biomarker to identify heart failure patients at risk for AF in whom aldosterone antagonism may attenuate such risk.